Ovid Therapeutics
OVID
OVID
62 hedge funds and large institutions have $73.7M invested in Ovid Therapeutics in 2019 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 22 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
15.93% more ownership
Funds ownership: 21.21% → 37.15% (+16%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
62
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$12M | |
| 2 | +$8.65M | |
| 3 | +$3.6M | |
| 4 |
Citigroup
New York
|
+$2.07M |
| 5 |
Renaissance Technologies
New York
|
+$2.07M |
Top Sellers
| 1 | -$6.59M | |
| 2 | -$59K | |
| 3 | -$41K | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$34K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$32.8K |